for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

InnoCare Pharma Ltd

9969.HK

Latest Trade

13.18HKD

Change

-0.26(-1.93%)

Volume

1,707,000

Today's Range

13.14

 - 

13.86

52 Week Range

12.48

 - 

32.05

As of on the Hong Kong Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
13.44
Open
13.28
Volume
1,707,000
3M AVG Volume
52.04
Today's High
13.86
Today's Low
13.14
52 Week High
32.05
52 Week Low
12.48
Shares Out (MIL)
1,499.67
Market Cap (MIL)
20,185.60
Forward P/E
241.65
Dividend (Yield %)
--

Next Event

InnoCare Pharma Ltd Annual Shareholders Meeting

Latest Developments

More

Innocare Pharma Says Recorded Qtrly Sales Of Orelabrutinib Of RMB74 Mln

Innocare Pharma Announces Inclusion Of Orelabrutinib In China National Reimbursement Drug List

InnoCare, Keymed Jointly Report Approval of Clinical Trial of CD20xCD3 Bispecific Antibody CM355

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About InnoCare Pharma Ltd

InnoCare Pharma Limited is an investment holding company mainly engaged in biomedical business. The Company discovers, develops and commercializes potentially best-in-class and first-in-class drugs for the treatment of cancer and autoimmune diseases. The Company builds a fully integrated biopharmaceutical platform with strong in-house research and development capabilities, including drug target identification and verification, preclinical evaluation, clinical trial design and execution, drug manufacturing and quality control, and commercialization.

Industry

Biotechnology & Drugs

Contact Info

+86.10.66609999

http://www.innocarepharma.com/

Key Stats

1.90 mean rating - 10 analysts
Sell
Hold
Buy
Revenue (MM, CNY)

2020

0.0K

2021(E)

1.0K
EPS (CNY)

2020

-0.480

2021(E)

0.031
Price To Earnings (TTM)
--
Price To Sales (TTM)
161.05
Price To Book (MRQ)
3.02
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
22.90
LT Debt To Equity (MRQ)
22.53
Return on Investment (TTM)
-4.66
Return on Equity (TTM)
-4.54

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up